PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease Reportsbullous pemphigoid
MeSH D010391 - bullous pemphigoid
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D001327:Autoimmune diseases
1 Company
1 Drug
$
Success rate
D012872:Vesiculobullous skin diseases
0 Companies
0 Drugs
Success rate
D010391: 
Bullous pemphigoid
1 Company
1 Drug
$
Success rate
Events Timeline
Loading
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
100%
1/1
Phase 2
31%
5/16
Phase 3
50%
5/10
Approved: 1Overall Success rate: 16%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Eli Lilly
Mycophenolate sodium,
Edodekin alfa
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use